Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 28 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

7 trials in Phase 3/4

Results Transparency

0%

0 of 28 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
20(74.1%)
Phase 3
5(18.5%)
Phase 4
2(7.4%)
27Total
N/A(20)
Phase 3(5)
Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT05691049Not ApplicableCompleted

Evaluation of Efficacy and Safety of HCC_45 for the Correction of Acne Scars of the Face

Role: collaborator

NCT05590364Not ApplicableCompleted

Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands

Role: collaborator

NCT04239768Not ApplicableCompleted

Efficacy of an Antiage Aesthetic Treatment for the Middle and Inferior Third of the Face

Role: lead

NCT04113265Not ApplicableCompleted

Aesthetic Performance of an Injective Treatment for the Inner Thighs, Knees and Arms

Role: lead

NCT04002856Not ApplicableCompleted

Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck

Role: lead

NCT03881189Not ApplicableCompleted

Efficacy and Tolerance Evaluation of an Injective Treatment for the Area Around the Eyes

Role: lead

NCT03833687Not ApplicableCompleted

Aesthetic Performance of an Injective Treatment for the Skin Roughness and Laxity of Inner Arm and Abdomen

Role: lead

NCT03801343Not ApplicableCompleted

Efficacy and Tolerance Evaluation of an Amino Acid Food Supplement

Role: lead

NCT03273660Not ApplicableCompleted

Evaluation of the Re-volumizing Performance of Aliaxin (New Trademark)

Role: lead

NCT03484897Not ApplicableCompleted

Soothing and Barrier Restoration Activity of a Body Cream for Atopic Skin

Role: lead

NCT03464890Not ApplicableCompleted

Soothing and Re-epithelizing Activity of New Cosmetic Formulations in Comparison to Placebo and Untreated Control Area

Role: lead

NCT03425955Not ApplicableCompleted

Aesthetic Performance of an Intradermal Injection Treatment for Face Photoaging: Interstitial or Cushion Technique in Comparison to Bolus Technique at Five Points (Half - Face Method Within Subjects)

Role: lead

NCT03273504Not ApplicableCompleted

Efficacy Evaluation of the Activity of a Cosmetic Product (Topical Use) on Hair Regrowth vs Placebo

Role: lead

NCT03279159Not ApplicableCompleted

Hydrating Efficacy and Tolerance Evaluation of a Face Cream

Role: lead

NCT03276897Not ApplicableCompleted

Efficacy and Tolerance Evaluation of a "Revitalizing" Face Treatment

Role: lead

NCT03274154Not ApplicableCompleted

Efficacy and Tolerance Evaluation of an Anti-age Food Supplement

Role: lead

NCT03273556Not ApplicableCompleted

Evaluation of the Filler Performance on the Nasolabial Folds of Aliaxin® EV With and Without Lidocaine 0.3%

Role: lead

NCT03272750Not ApplicableCompleted

Evaluation of Tolerance and Trichological Efficacy of a Food Supplement

Role: lead

NCT03274232Not ApplicableCompleted

Face Photoaging: Efficacy and Tolerance Evaluation of an Intradermal Injective Treatment

Role: lead

NCT03270293Not ApplicableCompleted

Efficacy and Tolerance Evaluation of a Bio-revitalizing Product Containing Hyaluronic Acid With High and Low Molecular Weight

Role: lead